SQZ Biotechnologies EPS - Earnings per Share 2020-2023 | SQZ
SQZ Biotechnologies eps - earnings per share from 2020 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| SQZ Biotechnologies Annual EPS |
| 2022 |
$-2.76 |
| 2021 |
$-2.49 |
| 2020 |
$-9.35 |
| 2019 |
$-18.89 |
| SQZ Biotechnologies Quarterly EPS |
| 2023-03-31 |
$-0.60 |
| 2022-12-31 |
$-0.46 |
| 2022-09-30 |
$-0.77 |
| 2022-06-30 |
$-0.78 |
| 2022-03-31 |
$-0.75 |
| 2021-12-31 |
$-0.42 |
| 2021-09-30 |
$-0.80 |
| 2021-06-30 |
$-0.68 |
| 2021-03-31 |
$-0.59 |
| 2020-12-31 |
$9.51 |
| 2020-09-30 |
$-7.03 |
| 2020-06-30 |
$-5.74 |
| 2020-03-31 |
$-6.09 |
| 2019-12-31 |
$0.00 |
| 2019-09-30 |
$-4.58 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.018B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
